|
Ryan M. Schwarz is a Managing Director focused on U.S. venture and growth capital opportunities in the healthcare sector. Mr. Schwarz leads the healthcare investing practice in the U.S. Venture & Growth Capital Group with a particular focus on medical devices, medical technology and healthcare information technology. He is based in Washington, DC.
Mr. Schwarz previously served as a Vice President in the healthcare group at Robertson Stephens & Co. He was also an investment banker at Morgan Stanley & Co. Inc.
Mr. Schwarz received his J.D., magna cum laude from Harvard Law School and his M.B.A. with Distinction from Harvard Business School. He also received his A.B., magna cum laude from Duke University where he was elected Phi Beta Kappa and was an Angier B. Duke Scholar.
Mr. Schwarz is on the Board of Directors of AcuFocus, Inc., Endius, Inc., Fairchild Imaging, Inc., Liposonix, Inc., NeoVista, Inc., Primary Health, Inc., Proteus Biomedical, Inc. and Transport Pharmaceuticals, Inc. He was formerly a Director of ConnectiCare Holdings, Inc. (sold to Health Insurance Plan of Greater New York), and Heritage Health Systems, Inc. (sold to Universal American Financial Corp.).
Mr. Schwarz also serves on the Boards of certain charitable not-for-profit organizations in the Washington, DC area. | 